Print
HVTN 080
NCT00991354
Trial Details:
Phase:
I
Status:
Completed
Organizer developer:
VGX, HTVN
Start Date:
Product:
PENNVAX-B
Antigen:
Prime 1:
Prime Class:
Boost 1:
RandD/trials/Lists/ClinicalTrialsList
Boost 1 class:
Boost 2:
Boost 2 Class:
Boost 3:
Boost 3 Class:
Adjuvant:
Country:
Volunteers:
Env, gag, pol B
ClinicalTrials.gov Identifier:
Link: